Mitochondria are dynamic organelles that undergo fission and fusion. While they are essential for cellular metabolism, the effect of dysregulated mitochondrial dynamics on cellular metabolism is not fully understood. We previously found that transmembrane protein 135 (Tmem135) plays a role in the regulation of mitochondrial dynamics in mice. Mice homozygous for a Tmem135 mutation (Tmem135FUN025/FUN025) display accelerated aging and age-related disease pathologies in the retina including the retinal pigment epithelium (RPE). We also generated a transgenic mouse line globally overexpressing the Tmem135 gene (Tmem135 TG). In several tissues and cells that we studied such as the retina, heart, and fibroblast cells, we observed that the Tmem135 mutation causes elongated mitochondria, while overexpression of Tmem135 results in fragmented mitochondria. To investigate how abnormal mitochondrial dynamics affect metabolic signatures of tissues and cells, we identified metabolic changes in primary RPE cell cultures as well as heart, cerebellum, and hippocampus isolated from Tmem135FUN025/FUN025 mice (fusion > fission) and Tmem135 TG mice (fusion < fission) using nuclear magnetic resonance spectroscopy. Metabolomics analysis revealed a tissue-dependent response to Tmem135 alterations, whereby significant metabolic changes were observed in the heart of both Tmem135 mutant and TG mice as compared to wild-type, while negligible effects were observed in the cerebellum and hippocampus. We also observed changes in Tmem135FUN025/FUN025 and Tmem135 TG RPE cells associated with osmosis and glucose and phospholipid metabolism. We observed depletion of NAD+ in both Tmem135FUN025/FUN025 and Tmem135 TG RPE cells, indicating that imbalance in mitochondrial dynamics to both directions lowers the cellular NAD+ level. Metabolic changes identified in this study might be associated with imbalanced mitochondrial dynamics in heart tissue and RPE cells which can likely lead to functional abnormalities.
Impact statement
Mitochondria are dynamic organelles undergoing fission and fusion. Proper regulation of this process is important for healthy aging process, as aberrant mitochondrial dynamics are associated with several age-related diseases/pathologies. However, it is not well understood how imbalanced mitochondrial dynamics may lead to those diseases and pathologies. Here, we aimed to determine metabolic alterations in tissues and cells from mouse models with over-fused (fusion > fission) and over-fragmented (fusion < fission) mitochondria that display age-related disease pathologies. Our results indicated tissue-dependent sensitivity to these mitochondrial changes, and metabolic pathways likely affected by aberrant mitochondrial dynamics. This study provides new insights into how dysregulated mitochondrial dynamics could lead to functional abnormalities of tissues and cells.
ChenHDetmerSAEwaldAJGriffinEEFraserSEChanDC.Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol2003;
160:189–200
2.
OlichonAGuillouEDelettreCLandesTArnaune-PelloquinLEmorineLJMilsVDaloyauMHamelCAmati-BonneauPBonneauDReynierPLenaersGBelenguerP.Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta2006;
1763:500–9
3.
MearsJALacknerLLFangSIngermanENunnariJHinshawJE.Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission. Nat Struct Mol Biol2011;
18:20–6
4.
BernhardtDMullerMReichertASOsiewaczHD.Simultaneous impairment of mitochondrial fission and fusion reduces mitophagy and shortens replicative lifespan. Sci Rep2015;
5:7885
5.
YangCCChenDLeeSSWalterL.The dynamin-related protein DRP-1 and the insulin signaling pathway cooperate to modulate Caenorhabditis elegans longevity. Aging Cell2011;
10:724–8
6.
McQuibbanGALeeJRZhengLJuusolaMFreemanM.Normal mitochondrial dynamics requires rhomboid-7 and affects drosophila lifespan and neuronal function. Curr Biol2006;
16:982–9
7.
WanglerMFAssia BatzirNRobakLAKoenigMKBacinoCAScagliaFBellenHJ.The expanding neurological phenotype of DNM1L-related disorders. Brain2018;
141:e28
8.
El-HattabAWSuleimanJAlmannaiMScagliaF.Mitochondrial dynamics: biological roles, molecular machinery, and related diseases. Mol Genet Metab2018;
125:315–21
9.
ZuchnerSMersiyanovaIVMugliaMBissar-TadmouriNRochelleJDadaliELZappiaMNelisEPatitucciASenderekJParmanYEvgrafovOJonghePDTakahashiYTsujiSPericak-VanceMAQuattroneABattalogluEPolyakovAVTimmermanVSchroderJMVanceJM.Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet2004;
36:449–51
10.
RouzierCBannwarthSChaussenotAChevrollierAVerschuerenABonello-PalotNFragakiKCanoAPougetJPellissierJFProcaccioVChabrolBPaquis-FlucklingerV.
The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy ‘plus’ phenotype. Brain2012;
135:23–34
11.
Amati-BonneauPValentinoMLReynierPGallardoMEBornsteinBBoissiereACamposYRiveraHde la AlejaJGCarrocciaRIommariniLLabaugePFigarella-BrangerDMarcorellesPFurbyABeauvaisKLetournelFLiguoriRLa MorgiaCMontagnaPLiguoriMZannaCRugoloMCossarizzaAWissingerBVernyCSchwarzenbacherRMartinMAArenasJAyusoCGaresseRLenaersGBonneauDCarelliV.OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain2008;
131:338–51
12.
GerberSCharifMChevrollierAChaumetteTAngebaultCKaneMSParisAAlbanJQuilesMDelettreCBonneauDProcaccioVAmati-BonneauPReynierPLeruezSCalmonRBoddaertNFunalotBRioMBouccaraDMeunierISesakiHKaplanJHamelCPRozetJMLenaersG.Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission. Brain2017;
140:2586–96
13.
SongMMiharaKChenYScorranoLDornGW2nd.Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab2015;
21:273–86
14.
WaiTGarcia-PrietoJBakerMJMerkwirthCBenitPRustinPRuperezFJBarbasCIbanezBLangerT.Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science2015;
350:aad0116
15.
SpinelliJBHaigisMC.The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol2018;
20:745–54
16.
MoravaEvan den HeuvelLHolFde VriesMCHogeveenMRodenburgRJSmeitinkJA.Mitochondrial disease criteria: diagnostic applications in children. Neurology2006;
67:1823–6
17.
SchaeferAMTaylorRWTurnbullDMChinneryPF.The epidemiology of mitochondrial disorders–past, present and future. Biochim Biophys Acta2004;
1659:115–20
18.
ExilVJSilva AvilaDBenedettoAExilEAAdamsMRAuCAschnerM.Stressed-induced TMEM135 protein is part of a conserved genetic network involved in fat storage and longevity regulation in Caenorhabditis elegans. PLoS One2010;
5:e14228
19.
LeeWHHiguchiHIkedaSMackeELTakimotoTPattnaikBRLiuCChuLFSiepkaSMKrentzKJRubinsteinCDKalejtaRFThomsonJAMullinsRFTakahashiJSPintoLHIkedaA.Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-dependent retinal pathologies. Elife2016;
5:e19264
20.
LewisSATakimotoTMehrvarSHiguchiHDoebleyALStokesGSheibaniNIkedaSRanjiMIkedaA.The effect of Tmem135 overexpression on the mouse heart. PLoS One2018;
13:e0201986
21.
PintoLHVitaternaMHSiepkaSMShimomuraKLumayagSBakerMFennerDMullinsRFSheffieldVCStoneEMHeffronETakahashiJS.Results from screening over 9000 mutation-bearing mice for defects in the electroretinogram and appearance of the fundus. Vision Res2004;
44:3335–45
22.
VitaternaMHPintoLHTakahashiJS.Large-scale mutagenesis and phenotypic screens for the nervous system and behavior in mice. Trends Neurosci2006;
29:233–40
23.
ChenMMuckersieERobertsonMFraczekMForresterJVXuH.Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07. Invest Ophthalmol Vis Sci2008;
49:3699–706
24.
BhuteVJBaoXDunnKKKnutsonKRMcCurryECJinGLeeWHLewisSIkedaAPalecekSP.Metabolomics identifies metabolic markers of maturation in human pluripotent stem Cell-Derived cardiomyocytes. Theranostics2017;
7:2078–91
25.
BhuteVJPalecekSP.Metabolic responses induced by DNA damage and poly (ADP-ribose) polymerase (PARP) inhibition in MCF-7 cells. Metabolomics2015;
11:1779–91
26.
BhuteVJMaYBaoXPalecekSP.The poly (ADP-Ribose) polymerase inhibitor veliparib and radiation cause significant cell line dependent metabolic changes in breast cancer cells. Sci Rep2016;
6:36061
27.
MartineauETeaILoaecGGiraudeauPAkokaS.Strategy for choosing extraction procedures for NMR-based metabolomic analysis of mammalian cells. Anal Bioanal Chem2011;
401:2133–42
28.
BeckonertOKeunHCEbbelsTMBundyJHolmesELindonJCNicholsonJK.Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc2007;
2:2692–703
29.
WishartDSJewisonTGuoACWilsonMKnoxCLiuYDjoumbouYMandalRAziatFDongEBouatraSSinelnikovIArndtDXiaJLiuPYallouFBjorndahlTPerez-PineiroREisnerRAllenFNeveuVGreinerRScalbertA.HMDB 3.0–the human metabolome database in 2013. Nucleic Acids Res2013;
41:D801–7
30.
TulpanDLegerSBelliveauLCulfACuperlovic-CulfM.MetaboHunter: an automatic approach for identification of metabolites from 1H-NMR spectra of complex mixtures. BMC Bioinformatics2011;
12:400
DieterleFRossASchlotterbeckGSennH.Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem2006;
78:4281–90
33.
XiaJMandalRSinelnikovIVBroadhurstDWishartDS.MetaboAnalyst 2.0 – a comprehensive server for metabolomic data analysis. Nucleic Acids Res2012;
40:W127–33
34.
XiaJSinelnikovIVHanBWishartDS.MetaboAnalyst 3.0 – making metabolomics more meaningful. Nucleic Acids Res2015;
43:W251–7
35.
MatesJMSeguraJACampos-SandovalJALoboCAlonsoLAlonsoFJMarquezJ.Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol2009;
41:2051–61
36.
RizzoloLJPengSLuoYXiaoW.Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium. Prog Retin Eye Res2011;
30:296–323
37.
AmbatiJAtkinsonJPGelfandBD.Immunology of age-related macular degeneration. Nat Rev Immunol2013;
13:438–51
38.
de JongPT.Age-related macular degeneration. N Engl J Med2006;
355:1474–85
39.
TerlukMRKapphahnRJSoukupLMGongHGallardoCMontezumaSRFerringtonDA.Investigating mitochondria as a target for treating age-related macular degeneration. J Neurosci2015;
35:7304–11
BonilhaVL.Age and disease-related structural changes in the retinal pigment epithelium. Clin Ophthalmol2008;
2:413–24
42.
ChaoJRKnightKEngelALJankowskiCWangYMansonMAGuHDjukovicDRafteryDHurleyJBDuJ.Human retinal pigment epithelial cells prefer proline as a nutrient and transport metabolic intermediates to the retinal side. J Biol Chem2017;
292:12895–905
43.
HarperAEMillerRHBlockKP.Branched-chain amino acid metabolism. Annu Rev Nutr1984;
4:409–54
44.
HoutkooperRHArgmannCHoutenSMCantoCJeningaEHAndreuxPAThomasCDoenlenRSchoonjansKAuwerxJ.The metabolic footprint of aging in mice. Sci Rep2011;
1:134
45.
WesleyUVBhuteVJHatcherJFPalecekSPDempseyRJ.Local and systemic metabolic alterations in brain, plasma, and liver of rats in response to aging and ischemic stroke, as detected by nuclear magnetic resonance (NMR) spectroscopy. Neurochem Int2019;
127:113–24
46.
BrockerCThompsonDCVasiliouV.The role of hyperosmotic stress in inflammation and disease. Biomol Concepts2012;
3:345–64
47.
BoldyrevABulyginaELeinsooTPetrushankoITsuboneSAbeH.Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp Biochem Physiol B, Biochem Mol Biol2004;
137:81–8
48.
HipkissARBrownsonCBertaniMFRuizEFerroA.Reaction Of carnosine with aged proteins: another protective process?.Ann N Y Acad Sci2002;
959:285–94
NewgardCBAnJBainJRMuehlbauerMJStevensRDLienLFHaqqAMShahSHArlottoMSlentzCARochonJGallupDIlkayevaOWennerBRYancyWSJrEisensonHMusanteGSurwitRSMillingtonDSButlerMDSvetkeyLP.A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab2009;
9:311–26
52.
TaiESTanMLStevensRDLowYLMuehlbauerMJGohDLIlkayevaORWennerBRBainJRLeeJJLimSCKhooCMShahSHNewgardCB.Insulin resistance is associated with a metabolic profile of altered protein metabolism in chinese and Asian-Indian men. Diabetologia2010;
53:757–67
53.
WurtzPMakinenVPSoininenPKangasAJTukiainenTKettunenJSavolainenMJTammelinTViikariJSRonnemaaTKahonenMLehtimakiTRipattiSRaitakariOTJarvelinMRAla-KorpelaM.Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes2012;
61:1372–80
54.
McCormackSEShahamOMcCarthyMADeikAAWangTJGersztenREClishCBMoothaVKGrinspoonSKFleischmanA.Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes2013;
8:52–61
55.
RamboldASCohenSLippincott-SchwartzJ.Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell2015;
32:678–92
56.
BenadorIYVeliovaMMahdavianiKPetcherskiAWikstromJDAssaliEAAcin-PerezRShumMOliveiraMFCintiSSztalrydCBarshopWDWohlschlegelJACorkeyBELiesaMShirihaiOS.Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion. Cell Metab2018;
27:869–85.e6
BraidyNGuilleminGJMansourHChan-LingTPoljakAGrantR.Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One2011;
6:e19194
59.
GomesAPPriceNLLingAJMoslehiJJMontgomeryMKRajmanLWhiteJPTeodoroJSWrannCDHubbardBPMerckenEMPalmeiraCMde CaboRRoloAPTurnerNBellELSinclairDA.Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell2013;
155:1624–38
60.
MassudiHGrantRBraidyNGuestJFarnsworthBGuilleminGJ.Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One2012;
7:e42357
61.
MouchiroudLHoutkooperRHMoullanNKatsyubaERyuDCantoCMottisAJoYSViswanathanMSchoonjansKGuarenteLAuwerxJ.The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell2013;
154:430–41
62.
MouchiroudLHoutkooperRHAuwerxJ.NAD(+) metabolism: a therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol2013;
48:397–408
63.
CeruttiRPirinenELampertiCMarchetSSauveAALiWLeoniVSchonEADantzerFAuwerxJViscomiCZevianiM.NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab2014;
19:1042–9
64.
HoutkooperRHAuwerxJ.Exploring the therapeutic space around NAD+. J Cell Biol2012;
199:205–9
65.
KhanNAAuranenMPaetauIPirinenEEuroLForsstromSPasilaLVelagapudiVCarrollCJAuwerxJSuomalainenA.Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med2014;
6:721–31
